Related Experiment Videos
By-passing immunization. Human antibodies from V-gene libraries displayed on phage
J D Marks1, H R Hoogenboom, T P Bonnert
1MRC Centre for Protein Engineering, Cambridge, U.K.
Journal of Molecular Biology
|December 5, 1991
Summary
Researchers created human antibodies in bacteria by mimicking immune selection. This novel phage display method bypasses traditional immunization and hybridoma techniques for antibody discovery.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Traditional antibody production relies on animal immunization and hybridoma technology, which can be time-consuming and inefficient.
- Generating diverse human antibody libraries is crucial for developing targeted therapeutics and research tools.
Purpose of the Study:
- To develop a method for producing human antibodies in bacteria using phage display technology.
- To create and select functional single-chain variable fragment (scFv) antibodies against specific antigens.
Main Methods:
- Constructed diverse libraries of human immunoglobulin variable genes (VH, Vκ, Vλ) from peripheral blood lymphocytes using polymerase chain reaction (PCR).
- Created combinatorial libraries of scFv fragments by random assembly of VH and V-light chain genes.
- Selected antigen-binding phage through iterative panning and growth with specific antigens (turkey egg-white lysozyme, bovine serum albumin) or haptens (2-phenyloxazol-5-one).
- Sequenced selected V-genes and produced soluble antibody fragments for affinity analysis.
Main Results:
- Generated a phage display library with over 10^7 members encoding human antibody fragments.
- Successfully selected and sequenced antibody genes, identifying both germline and mutated variants.
- Demonstrated specific antigen and hapten binding by soluble antibody fragments with high affinities (Ka for TEL = 10^7 M^-1; Ka for phOx = 2 x 10^6 M^-1).
Conclusions:
- Phage display technology enables the isolation of human antibodies against diverse antigens without immunization.
- This method offers a powerful alternative to hybridoma technology for antibody discovery and development.
- Further optimization, such as using larger libraries, may yield even higher-affinity antibodies.